MedTrace Logo

Evaluation and Management for Prostate Oncology, Wellness, and Risk (EMPOWeR)

NCT03807492 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 241

Last updated 2025-05-15

No results posted yet for this study

Summary

The EMPOWeR study is proposed as a cohort study with longitudinal follow-up to determine rates of genetic mutations among men with or at-risk for prostate cancer to address the various facets of genetic education and counseling for optimized genetic assessment and wellness of men. The results will inform practice guidelines and future studies for maximal impact of genetic evaluation of men for inherited prostate cancer.

Conditions

Sponsors & Collaborators

  • Sidney Kimmel Cancer Center at Thomas Jefferson University

    lead OTHER

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-16
Primary Completion
2022-06-01
Completion
2024-02-07

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03807492 on ClinicalTrials.gov